1 Henri M: Session "Diabetes and Cancer". Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology, 29.9.-3.10.2017, Stuttgart.
2GrimmP, Ignace Billiet I, Bostwick D et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treated by radical therapy. Results from the Prostate Cancer Results Study Group. BJUI 109, Suppl 1, 22-29, 2012.
3ChaoMW, Grimm P, Yaxley J et al: Brachytherapy: state-of-the-art radiotherapy in prostate cancer. BJU Int. 2015 Oct;116 Suppl 3:80-8. doi: 10.1111/bju.13252. review.
4HenriM et al: Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer. PloS 2012;7(12):e50953. doi: 10.1371/journal.pone.0050953. epub 2012 Dec 10.